Literature DB >> 33248151

Type-2 muscle fiber atrophy is associated with sarcopenia in elderly men with hip fracture.

Fabiana Tanganelli1, Peter Meinke2, Fabian Hofmeister3, Stefanie Jarmusch3, Lisa Baber3, Stefan Mehaffey4, Stefan Hintze2, Uta Ferrari3, Carl Neuerburg4, Christian Kammerlander4, Benedikt Schoser2, Michael Drey3.   

Abstract

Sarcopenia is a common geriatric syndrome and can lead to falls and fragility fractures. It is associated with a decline of muscle fiber numbers and size. Muscle biopsies of the vastus lateralis muscle were taken from thirty-two patients with hip fracture (18 women and 14 men; mean age: 82.2 ± 6.2 years). Serial cross sections of skeletal muscle were labeled with myosin heavy chain slow (fiber type-1) and fast (fiber type-2) antibodies in order to measure the size, ratio and percentage of mixed fiber types. The presence of sarcopenia was defined according to the EWGSOP2 criteria by using BIA and handgrip strength measurement. Sarcopenia was identified in 5 patients (3 women and 2 men), probable-sarcopenia in 11 patients (4 women and 7 men). Significant differences in fiber diameter were found for fiber type-2 in men but not in women. Only 1-3% mixed fiber types were found in sarcopenic patients, indicating a final stage where reinnervation is not possible to occur anymore. Muscle fiber type-2 atrophy seems to be a histological marker for sarcopenia in men.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hip fracture; Muscle histology; Sarcopenia; Type-2 muscle fiber atrophy

Mesh:

Year:  2020        PMID: 33248151     DOI: 10.1016/j.exger.2020.111171

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  5 in total

Review 1.  Diabetes mellitus tendino-myopathy: epidemiology, clinical features, diagnosis and management of an overlooked diabetic complication.

Authors:  Hayder A Giha; Mai S Sater; Osman A O Alamin
Journal:  Acta Diabetol       Date:  2022-03-15       Impact factor: 4.280

2.  [Diagnostic and therapeutic approach to sarcopenia].

Authors:  Anna Schaupp; Sebastian Martini; Ralf Schmidmaier; Michael Drey
Journal:  Z Gerontol Geriatr       Date:  2021-09-20       Impact factor: 1.281

3.  Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions.

Authors:  Angelique Stalmach; Ines Boehm; Marco Fernandes; Alison Rutter; Richard J E Skipworth; Holger Husi
Journal:  Molecules       Date:  2022-08-27       Impact factor: 4.927

4.  Suppressive Effects of Turmeric Extract on Muscle Atrophy in Dexamethasone-Treated Mice and Myotubes.

Authors:  Kyohei Furukawa; Marika Kousaka; Huijuan Jia; Hisanori Kato
Journal:  Nutrients       Date:  2022-09-25       Impact factor: 6.706

5.  Late-onset neuromuscular disorders in the differential diagnosis of sarcopenia.

Authors:  Fabian Hofmeister; Lisa Baber; Uta Ferrari; Stefan Hintze; Stefanie Jarmusch; Sabine Krause; Peter Meinke; Stefan Mehaffey; Carl Neuerburg; Fabiana Tangenelli; Benedikt Schoser; Michael Drey
Journal:  BMC Neurol       Date:  2021-06-25       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.